Skip to content

We are supported by referral fees from the advertisers presented on this site. We do not present information about every advertiser or offer available.

Semaglutide.now
Semaglutide

Shed vs Wellorithm: Coaching and 50-State Access Compared

Shed vs Wellorithm answers which telehealth GLP-1 platform fits your priorities. Early verdict: pick Shed if you want name-brand options and ongoing coaching; pick Wellorithm if broad 50-state clinician access and lower starting pricing matter most.

Start Shed 2-Minute Assessment

Shed vs Wellorithm at a glance

Both platforms deliver GLP-1 programs through virtual assessments and clinician review, but they differ on medication type, coaching, national coverage, and starting price. Below are the most distinctive supported differences between Shed and Wellorithm.

Distinctive difference 1: Name-brand availability

Shed: Offers both FDA-approved name-brand GLP-1 and compounded alternatives. The provider notes name-brand options carry significantly higher costs than compounded alternatives and that compounded medications are not FDA-approved and are prepared by a licensed pharmacy based on a provider’s prescription.

Wellorithm: Offers compounded semaglutide and tirzepatide only. Wellorithm explicitly lists compounded medications and does not offer branded Ozempic, Wegovy, or Zepbound.

Distinctive difference 2: Coaching vs prescription-only model

Shed: Integrates continuous coaching into treatment. Shed positions coaching as part of its treatment model rather than simply issuing a prescription, supporting titration and lifestyle change throughout the program.

Wellorithm: Described as fully virtual consultations with medication shipped to the home. The evidence highlights virtual check ins for titration but does not describe an integrated coaching program equivalent to Shed’s continuous coaching.

Distinctive difference 3: Clinician coverage and access

Wellorithm: Has licensed clinicians in all 50 states, which the provider frames as an advantage for patients in states with limited GLP-1 telehealth options.

Shed: Evidence shows Shed is a licensed telehealth platform with clinician review after a 2-minute assessment, but the source does not claim 50-state clinician coverage.

Distinctive difference 4: Pricing signals and introductory offers

Shed: Lists compounded semaglutide starting at $199 per month and compounded tirzepatide starting at $299 per month, and offers 10% off your first month. Shed also notes it does not publish standard pricing and provides personalized quotes after intake for name-brand versus compounded choices.

Wellorithm: Advertises starting prices as low as $147 for some compounded options, notes “Only $147 + Fast, Free Shipping” and several “starting at” bullet points. Wellorithm also promotes a $100 off first month offer on multiple items. Both platforms state final pricing requires an intake or quiz and that pricing is personalized.

Direct comparison table

Criteria Shed Wellorithm
Medication types Name-brand and compounded GLP-1 Compounded semaglutide and tirzepatide only
Coaching Continuous integrated coaching Virtual consultations and check ins; no integrated coaching claim supplied
Clinician coverage Licensed clinician review after 2-minute assessment Licensed clinicians in all 50 states
Starting price shown Compounded semaglutide starting at $199/month; compounded tirzepatide $299/month; 10% off first month Some options starting at $147; various starts at $249 and up; “Only $147 + Fast, Free Shipping”; $100 off first month on select items
Regulatory note Compounded medications are not FDA-approved Compounded medications are not FDA-approved

How the platforms actually work

Shed uses a 2-minute online assessment to check eligibility, then a licensed clinician reviews the case and issues a prescription when appropriate. Medication is shipped and coaching begins as part of the plan. Wellorithm also uses a 2-minute quiz, then a licensed clinician in your state reviews your case and prescribes a compounded GLP-1 program with medication shipped to your home.

See Shed options and coaching

Safety and regulatory reminders

Both providers state that compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness, or quality. Both require a licensed clinician to determine whether treatment is medically appropriate before prescribing.

Final comparison summary

In short, Shed vs Wellorithm splits on name-brand availability and coaching versus national clinician coverage and lower starting compounded pricing. Shed bundles coaching and offers both name-brand and compounded options with a stated compounded semaglutide starting at $199 and 10% off the first month. Wellorithm focuses on compounded products, advertises starts at $147 with free shipping and clinicians in all 50 states.

Start Wellorithm 2-Minute Quiz

Choose based on what matters

Choose Shed if you want the option of FDA-approved name-brand GLP-1 plus an integrated coaching program and a quick 2-minute approval assessment, and you accept that name-brand options may carry higher cost and that standard pricing may be personalized.

Choose Wellorithm if you need licensed clinician access in all 50 states, prefer compounded-only options with lower advertised starting prices such as $147, and value free shipping and a fully virtual consultation model.

Compare Shed treatment plans

Compare Wellorithm treatment plans

Ready to Compare GLP-1 Providers?

Explore leading providers — physician-supervised, all-inclusive pricing, and free home delivery.

Compare All Providers →

Leave a comment

Medical disclaimer: This page is for informational purposes only and is not medical advice. Always consult a licensed healthcare provider before starting any treatment.